The chemical class termed PCDHB14 Activators refers to a group of compounds that have the ability to increase the expression of Protocadherin Beta 14 (PCDHB14), a protein that is part of the protocadherin family. These activators are characterized by their diverse chemical structures and their capacity to interact with cellular mechanisms to promote the transcription or stabilization of the PCDHB14 mRNA or protein. The scope of compounds that can be classified as PCDHB14 Activators is broad, as their modes of action can vary widely. Some may interact with the promoter regions of the gene encoding PCDHB14 to enhance transcription, while others may function by altering the epigenetic landscape, thus making the PCDHB14 gene more accessible to transcription machinery. Additionally, certain PCDHB14 Activators might work by stabilizing PCDHB14 mRNA, thereby increasing translation and protein levels.
The mechanisms by which PCDHB14 Activators function are as intricate as the pathways that regulate gene expression itself. These compounds can induce signaling cascades that culminate in the transcriptional activation of PCDHB14, such as the upregulation of transcription factors or the modulation of chromatin structure through histone modification enzymes. Some activators may act by inhibiting negative regulators of PCDHB14 expression, thereby relieving repression and allowing gene expression to proceed. The activation process can be highly cell-type or tissue-specific, reflecting the complex regulatory networks that control protocadherin expression. These activators are of interest to researchers who aim to understand the regulation of neural gene expression and the molecular underpinnings of neural development and function. The study of PCDHB14 Activators sheds light on the sophisticated control systems governing cellular function and the ability for modulation of gene expression within these systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound can inhibit DNA methyltransferases, which may result in the hypomethylation of gene promoters and activate gene expression, including possibly PCDHB14. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
As a histone deacetylase inhibitor, this compound can increase histone acetylation, promoting transcriptional activation of various genes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
It activates adenylyl cyclase, increasing cAMP levels that may lead to the activation of CREB signaling and induction of gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 18 | |
Sodium butyrate acts as a histone deacetylase inhibitor, leading to a more relaxed chromatin structure and potential upregulation of gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid binds to retinoic acid receptors, which can regulate gene expression by acting as transcription factors, potentially affecting PCDHB14. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
It can regulate gene expression by binding to estrogen receptors, which may interact with promoter regions of genes, including PCDHB14. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
This glucocorticoid receptor agonist can modulate gene expression by binding to glucocorticoid response elements in the genome. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $70.00 $160.00 $290.00 | 2 | |
The active metabolite can bind to the vitamin D receptor, potentially affecting the transcription of various genes, including PCDHB14. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
As a polyphenol, EGCG may modulate gene expression through its effects on cell signaling pathways and epigenetic modifications. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium can inhibit GSK-3β, leading to changes in signaling pathways that may result in altered gene expression patterns. |